作者:Stefano Crosignani、Marc Missotten、Christophe Cleva、Ruggero Dondi、Yann Ratinaud、Yves Humbert、Ashis Baran Mandal、Agnès Bombrun、Christine Power、André Chollet、Amanda Proudfoot
DOI:10.1016/j.bmcl.2010.04.113
日期:2010.6
The discovery of a novel series of CXCR3 antagonists is described. Starting from an HTS positive, iterative optimization gave potent compounds (IC(50) 15 nM in a chemotaxis assay). The strategy employed to improve the metabolic stability of these derivatives is described. (C) 2010 Elsevier Ltd. All rights reserved.